US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
ETF
アメリカ
AMEX
Invesco Variable Rate Preferred ETF (VRP)
Invesco Variable Rate Preferred ETF (VRP) ニュース

VRP

Invesco Variable Rate Pr... (VRP)

Invesco Variable Rate Preferred ETF

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:VRP

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/02/18	16 : 00	GlobeNewswire Inc.	Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
2021/02/02	20 : 17	GlobeNewswire Inc.	CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
2021/02/02	16 : 00	GlobeNewswire Inc.	Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
2021/01/14	16 : 00	GlobeNewswire Inc.	Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19	AMEX:VRP	Invesco Variable Rate Preferred ETF
2021/01/05	16 : 00	GlobeNewswire Inc.	Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/11/09	16 : 00	GlobeNewswire Inc.	Verona Pharma Announces November 2020 Virtual Investor Conference Participation	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/10/29	16 : 00	GlobeNewswire Inc.	Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/10/22	15 : 00	GlobeNewswire Inc.	Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update...	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/10/13	15 : 00	GlobeNewswire Inc.	Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/09/08	15 : 00	GlobeNewswire Inc.	Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/09/02	15 : 00	GlobeNewswire Inc.	Verona Pharma to Present at H.C. Wainwright 22nd Annual Global Virtual Investment Conference	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/08/24	15 : 00	GlobeNewswire Inc.	Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2...	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/08/19	15 : 00	GlobeNewswire Inc.	Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/08/14	15 : 00	GlobeNewswire Inc.	Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/08/03	15 : 00	GlobeNewswire Inc.	Verona Pharma Announces August 2020 Virtual Investor Conference Participation	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/07/30	15 : 00	GlobeNewswire Inc.	Verona Pharma to Announce Interim Results for the Three and Six Months Ended June 30, 2020 and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/07/17	15 : 00	GlobeNewswire Inc.	Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/05/14	15 : 00	GlobeNewswire Inc.	Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANC...	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/05/02	01 : 12	GlobeNewswire Inc.	Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic...	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/04/30	15 : 00	GlobeNewswire Inc.	Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/04/23	15 : 00	GlobeNewswire Inc.	Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/04/16	20 : 12	GlobeNewswire Inc.	Verona Pharma plc: Results of AGM	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/04/08	15 : 00	GlobeNewswire Inc.	Update on AGM Procedure	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/03/31	15 : 00	GlobeNewswire Inc.	Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/03/17	02 : 13	GlobeNewswire Inc.	2019 Annual Report and Accounts and Notice of AGM	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/02/27	16 : 00	GlobeNewswire Inc.	Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/02/21	16 : 00	GlobeNewswire Inc.	Verona Pharma plc to Announce Financial Results for Full Year Ended December 31, 2019 and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/02/14	16 : 00	GlobeNewswire Inc.	Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/02/03	16 : 00	GlobeNewswire Inc.	Verona Pharma Announces Senior Management Changes	AMEX:VRP	Invesco Variable Rate Preferred ETF
2020/01/13	14 : 00	GlobeNewswire Inc.	Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium T...	AMEX:VRP	Invesco Variable Rate Preferred ETF

Showing the most relevant articles for your search:AMEX:VRP

Gold vs US Dollar

JP Morgan Chase

BNP Paribas (QX)

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約